| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.05 |